Pricing Log in Create free account

Labcorp Holdings Inc. (LH) vs Revvity Inc. (RVTY)

Labcorp Holdings Inc. and Revvity Inc. are both Diagnostics & Research companies. Labcorp Holdings Inc. is the larger, with a market value of $26.4B against $17.3B — 1.5× the size. Labcorp Holdings Inc. trades at the lower P/E: 26.2× against 72.7×. Labcorp Holdings Inc. grew revenue faster over the last twelve months: 6.41% against 4.05%. Revvity Inc. has the higher net margin (8.16% vs 6.99%) and the lower return on invested capital (2.38% vs 6.50%). Both pay a dividend; Labcorp Holdings Inc. yields more (0.90% vs 0.23%). Across the 23 metrics below, Labcorp Holdings Inc. leads on 15 and Revvity Inc. on 8.

Valuation

Metric LH RVTY Diagnostics & Research median
P/E 26.18 72.69 35.56
P/S 1.81 5.85 4.37
P/B 3.02 2.36 3.06
Price to free cash flow 25.22 30.14 35.76
EV/EBITDA 14.51 24.77 24.35
EV/Sales 2.22 6.60 5.51
Earnings yield 3.82% 1.38% (1.89%)
Free cash flow yield 3.97% 3.32% (0.15%)

Profitability

Metric LH RVTY Diagnostics & Research median
Gross margin 28.88% 54.98% 50.89%
Operating margin 10.43% 12.32% (8.57%)
Net margin 6.99% 8.16% (6.37%)
Free cash flow margin 8.16% 19.58% 0.00%
Return on equity 11.74% 3.21% (2.92%)
Return on assets 5.48% 1.95% (6.71%)
Return on invested capital 6.50% 2.38% 0.00%

Growth

Metric LH RVTY Diagnostics & Research median
Revenue growth (TTM) 6.41% 4.05% 7.69%
EPS growth (last fiscal year) 18.33% (5.91%) 25.92%
Revenue growth, 5-year CAGR (0.04%) 1.41% 7.40%
Net income growth, 5-year CAGR (10.85%) (19.82%) 0.00%

Health

Metric LH RVTY Diagnostics & Research median
Debt to equity 0.69 0.44 0.11
Current ratio 1.80 1.80 2.02
Net debt to EBITDA 2.23 3.00 0.70

Dividend

Metric LH RVTY Diagnostics & Research median
Dividend yield 0.90% 0.23% 0.66%
Payout ratio 0.24 0.17 0.20

Size

Metric LH RVTY Diagnostics & Research median
Market cap 26.36b 17.26b 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack